Using knockdown or pharmacological inhibition approaches, Schinke and colleagues showed that inhibition of IL-8RB-mediated signaling leads to a significant reduction in proliferation and G0/G1 cell cycle arrest in several leukemic cell lines and primary MDS/AML samples (119). Here, CXCR2 is linked to acute myeloid leukemia.